100 related articles for article (PubMed ID: 35654343)
1. Letter to editor about the articles of "Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections".
Lin HC; Tseng CF; Cheng-Chung Wei J
Brain Behav Immun; 2022 Aug; 104():216. PubMed ID: 35654343
[No Abstract] [Full Text] [Related]
2. Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections.
Taquet M; Dercon Q; Harrison PJ
Brain Behav Immun; 2022 Jul; 103():154-162. PubMed ID: 35447302
[TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
Almendro-Vázquez P; Chivite-Lacaba M; Utrero-Rico A; González-Cuadrado C; Laguna-Goya R; Moreno-Batanero M; Sánchez-Paz L; Luczkowiak J; Labiod N; Folgueira MD; Delgado R; Paz-Artal E
Front Immunol; 2022; 13():981350. PubMed ID: 36059485
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at midterm after Comirnaty® COVID-19 vaccination.
Torres I; Bellido-Blasco JB; Gimeno C; Burgos JS; Albert E; Moya-Malo R; Gascó-Laborda JC; Tornero A; Soriano J; Meseguer-Ferrer N; Martínez-Serrano M; Ortíz-Rambla J; Buj H; Hernández N; Peiró S; Salas D; Limón R; Vanaclocha H; Sánchez-Payá J; Díez-Domingo J; Comas I; González-Candelas F; Navarro D;
J Med Virol; 2022 Aug; 94(8):3776-3782. PubMed ID: 35445415
[TBL] [Abstract][Full Text] [Related]
5. Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections.
Stærke NB; Reekie J; Nielsen H; Benfield T; Wiese L; Knudsen LS; Iversen MB; Iversen K; Fogh K; Bodilsen J; Juhl MR; Lindvig SO; Øvrehus A; Madsen LW; Klastrup V; Andersen SD; Juhl AK; Andreasen SR; Ostrowski SR; Erikstrup C; Fischer TK; Tolstrup M; Østergaard L; Johansen IS; Lundgren J; Søgaard OS
Nat Commun; 2022 Aug; 13(1):4466. PubMed ID: 35915081
[TBL] [Abstract][Full Text] [Related]
6. Serological Response and Clinical Protection of Anti-SARS-CoV-2 Vaccination and the Role of Immunosuppressive Drugs in a Cohort of Kidney Transplant Patients.
Biagio P; Rosa C; Nicola SM; Fabrizio S; Amerigo P; Giulia Z; Riccardo S; Riccardo V; Paolo R; Lorenzo S; Ivan G; Federico Ii Covid Team
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146758
[TBL] [Abstract][Full Text] [Related]
7. Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections.
Möhlendick B; Čiučiulkaitė I; Elsner C; Anastasiou OE; Trilling M; Wagner B; Zwanziger D; Jöckel KH; Dittmer U; Siffert W
Front Immunol; 2022; 13():907343. PubMed ID: 35812411
[TBL] [Abstract][Full Text] [Related]
8. Persistent B cell memory after SARS-CoV-2 vaccination is functional during breakthrough infections.
Terreri S; Piano Mortari E; Vinci MR; Russo C; Alteri C; Albano C; Colavita F; Gramigna G; Agrati C; Linardos G; Coltella L; Colagrossi L; Deriu G; Ciofi Degli Atti M; Rizzo C; Scarsella M; Brugaletta R; Camisa V; Santoro A; Roscilli G; Pavoni E; Muzi A; Magnavita N; Scutari R; Villani A; Raponi M; Locatelli F; Perno CF; Zaffina S; Carsetti R
Cell Host Microbe; 2022 Mar; 30(3):400-408.e4. PubMed ID: 35134333
[TBL] [Abstract][Full Text] [Related]
9. Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California.
Servellita V; Morris MK; Sotomayor-Gonzalez A; Gliwa AS; Torres E; Brazer N; Zhou A; Hernandez KT; Sankaran M; Wang B; Wong D; Wang C; Zhang Y; Reyes KR; Glasner D; Deng X; Streithorst J; Miller S; Frias E; Rodgers M; Cloherty G; Hackett J; Hanson C; Wadford D; Philip S; Topper S; Sachdev D; Chiu CY
Nat Microbiol; 2022 Feb; 7(2):277-288. PubMed ID: 35013591
[TBL] [Abstract][Full Text] [Related]
10. Breakthrough SARS-CoV-2 infections after vaccination: a critical review.
Mohseni Afshar Z; Barary M; Hosseinzadeh R; Alijanpour A; Hosseinzadeh D; Ebrahimpour S; Nazary K; Sio TT; Sullman MJM; Carson-Chahhoud K; Babazadeh A
Hum Vaccin Immunother; 2022 Nov; 18(5):2051412. PubMed ID: 35302905
[TBL] [Abstract][Full Text] [Related]
11. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
[TBL] [Abstract][Full Text] [Related]
12. The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
Koutsakos M; Lee WS; Reynaldi A; Tan HX; Gare G; Kinsella P; Liew KC; Taiaroa G; Williamson DA; Kent HE; Stadler E; Cromer D; Khoury DS; Wheatley AK; Juno JA; Davenport MP; Kent SJ
Immunity; 2022 Jul; 55(7):1316-1326.e4. PubMed ID: 35690062
[TBL] [Abstract][Full Text] [Related]
13. Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2.
Soegiarto G; Wulandari L; Purnomosari D; Dhia Fahmita K; Ikhwan Gautama H; Tri Hadmoko S; Edwin Prasetyo M; Aulia Mahdi B; Arafah N; Prasetyaningtyas D; Prawiro Negoro P; Rosita Sigit Prakoeswa C; Endaryanto A; Gede Agung Suprabawati D; Tinduh D; Basuki Rachmad E; Astha Triyono E; Wahyuhadi J; Budi Keswardiono C; Elyana Wardani F; Mayorita F; Kristiani N; Baskoro A; Fetarayani D; Kartika Nurani W; Oceandy D
Vaccine; 2022 Jun; 40(30):4046-4056. PubMed ID: 35660034
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine.
Gallais F; Gantner P; Planas D; Solis M; Bruel T; Pierre F; Soulier E; Rossolillo P; Fourati S; Sibilia J; Schwartz O; Fafi-Kremer S
Front Immunol; 2022; 13():790212. PubMed ID: 35281046
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and Persistence of the Cellular and Humoral Immune Responses to BNT162b2 mRNA Vaccine in SARS-CoV-2-Naive and -Experienced Subjects: Impact of Booster Dose and Breakthrough Infections.
Desmecht S; Tashkeev A; El Moussaoui M; Marechal N; Perée H; Tokunaga Y; Fombellida-Lopez C; Polese B; Legrand C; Wéry M; Mni M; Fouillien N; Toussaint F; Gillet L; Bureau F; Lutteri L; Hayette MP; Moutschen M; Meuris C; Vermeersch P; Desmecht D; Rahmouni S; Darcis G
Front Immunol; 2022; 13():863554. PubMed ID: 35711445
[TBL] [Abstract][Full Text] [Related]
16. Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?
van den Hoogen LL; Smits G; van Hagen CCE; Wong D; Vos ERA; van Boven M; de Melker HE; van Vliet J; Kuijer M; Woudstra L; Wijmenga-Monsuur AJ; GeurtsvanKessel CH; Stoof SP; Reukers D; Wijsman LA; Meijer A; Reusken CBEM; Rots NY; van der Klis FRM; van Binnendijk RS; den Hartog G
Vaccine; 2022 Apr; 40(15):2251-2257. PubMed ID: 35287986
[TBL] [Abstract][Full Text] [Related]
17. Cross-Variant Neutralizing Serum Activity after SARS-CoV-2 Breakthrough Infections.
Tober-Lau P; Gruell H; Vanshylla K; Koch WM; Hillus D; Schommers P; Suárez I; Suttorp N; Sander LE; Klein F; Kurth F
Emerg Infect Dis; 2022 May; 28(5):1050-1052. PubMed ID: 35259088
[TBL] [Abstract][Full Text] [Related]
18. A case report of breakthrough infection with the SARS-CoV-2 delta variant and household transmission: Role of vaccination, anti-spike IgG and neutralizing activity.
Moriyama Y; Ishikane M; Ueno M; Matsunaga A; Ishizaka Y; Arashiro T; Kanno T; Suzuki T; Kimura K
J Infect Chemother; 2022 Jul; 28(7):962-964. PubMed ID: 35461768
[TBL] [Abstract][Full Text] [Related]
19. Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy.
Sormani MP; Schiavetti I; Inglese M; Carmisciano L; Laroni A; Lapucci C; Visconti V; Serrati C; Gandoglia I; Tassinari T; Perego G; Brichetto G; Gazzola P; Mannironi A; Stromillo ML; Cordioli C; Landi D; Clerico M; Signoriello E; Cocco E; Frau J; Ferrò MT; Di Sapio A; Pasquali L; Ulivelli M; Marinelli F; Pizzorno M; Callari G; Iodice R; Liberatore G; Caleri F; Repice AM; Cordera S; Battaglia MA; Salvetti M; Franciotta D; Uccelli A;
EBioMedicine; 2022 Jun; 80():104042. PubMed ID: 35526306
[TBL] [Abstract][Full Text] [Related]
20. Letter to the Editor: What is the actual role of decompensated cirrhosis in the breakthrough SARS-CoV-2 infection?
Hu Y; Li Z; He W; Wang X; Cheng X
Hepatology; 2023 Oct; 78(4):E76-E77. PubMed ID: 37459555
[No Abstract] [Full Text] [Related]
[Next] [New Search]
